在结直肠癌中涉及的信号通路:病原和向治疗
Qing Li1,2,3, Shan Geng4, Hao Luo3,5
1The Shapingba Hospital, Chongqing University, Chongqing, China.
Signal transduction and targeted therapy
|October 6, 2024
概括
大肠直肠癌 (CRC) 涉及复杂的信号通路失调. 了解这些途径有助于开发有针对性的疗法和个性化药物,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题,由复杂的信号传导网络失调驱动.
- 异常的信号通路控制关键的细胞过程,如增殖,生存,分化和亡,导致CRC的发展.
- 了解这些分子基础对于有效的治疗策略至关重要.
研究的目的:
- 剖析结直肠癌 (CRC) 发病过程中的基本信号机制.
- 阐明CRC中瘤进化和进展的原则.
- 审查向和免疫疗法的进展,由瘤原体信号传递提供信息.
主要方法:
- 审查CRC的分子标志,包括基因组,表观基因组和微生物特征.
- 分析信号传导在编排瘤发生过程中的作用.
- 评估向和免疫疗法的影响和AI的潜在整合.
主要成果:
- 信号传导网络的失调是CRC病变的核心.
- 针对性和免疫疗法已经出现,基于对瘤原体信号的理解.
- 人工智能集成显示了精确治疗准和患者分层的前景.
结论:
- 在CRC病变发生过程中的异常信号需要有针对性的治疗策略.
- 对信号通路的深入理解推动了个性化医疗方法.
- 未来的方向包括利用人工智能提高CRC治疗的精度.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


